Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Depression in Parkinson's disease -- a review.

• Abraham Lieberman
• Acta neurologica Scandinavica
• 2006

Major depression is present, at any given time, in 20-40% of Parkinson's disease (PD) patients, several times the prevalence in the general population. In addition, depression may precede the… (More)

A Mobile Cloud-Based Parkinson’s Disease Assessment System for Home-Based Monitoring

• Di Pan, Rohit Dhall, Abraham Lieberman, Diana B. Petitti
• JMIR mHealth and uHealth
• 2015

BACKGROUND Parkinson's disease (PD) is the most prevalent movement disorder of the central nervous system, and affects more than 6.3 million people in the world. The characteristic motor features… (More)

Temporal dissociation of the prehension pattern in Parkinson's disease.

• Umberto Castiello, George E. Stelmach, Abraham Lieberman
• Neuropsychologia
• 1993

This study assesses the reach to grasp movement of eight Parkinson and eight control subjects. The reach was of either 15, 27.5 or 40 cm. The grasp was either of a small (0.7 cm) or a large diameter… (More)

Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons.

• Deborah C. Mash, Qinjie Ouyang, +4 authors Richard Justin Perrin
• The Journal of neuroscience : the official…
• 2003

Alpha-synuclein is a presynaptic protein that has been implicated as a possible causative agent in the pathogenesis of Parkinson's disease. The native protein is a major component of nigral Lewy… (More)

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

• M. Flint Beal, David Oakes, +158 authors Karyn Boyar
• JAMA neurology
• 2014

IMPORTANCE Coenzyme Q10 (CoQ10), an antioxidant that supports mitochondrial function, has been shown in preclinical Parkinson disease (PD) models to reduce the loss of dopamine neurons, and was safe… (More)

Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog.

• Abraham Lieberman, J. L. Weiss, +6 authors Myron L. Weisfeldt
• Circulation
• 1981

To study endocardial wall motion and thickness as indexes of infarction, we used two-dimensional echocardiography to examine regional percentages of systolic wall thickening (%Th) and endocardial… (More)

Prevalence of tremor and Parkinson's disease.

• Ashish Khatter, Meike Kurth, +7 authors Abraham Lieberman
• Parkinsonism & related disorders
• 1996

To determine the prevalence of essential tremor (ET) and Parkinson's disease (PD) in a retirement community, all residents of Carefree, Arizona, aged over 65 years were contacted. All participants… (More)

Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.

• Abraham Lieberman, Andreas Neophytides, +5 authors M. Goldstein
• Advances in neurology
• 1983

Treatment with pergolide was compared with bromocriptine in 25 patients, all of whom were also receiving levodopa and in all of whom the response to levodopa had diminished. All 25 patients had… (More)

Are dementia and depression in Parkinson's disease related?

• Abraham Lieberman
• Journal of the neurological sciences
• 2006

INTRODUCTION Depression and dementia are common problems in PD. As the depression and dementia of PD share many symptoms such as apathy, anhedonia, anergia, and agitation, it is reasonable to ask if… (More)

Dysphagia in Parkinson's disease.

• Abraham Lieberman, Lisa M. Horowitz, Peter Redmond, Lior Pachter, Isador Lieberman, Morton Leibowitz
• The American journal of gastroenterology
• 1980

• ‹
• 1
• 2
• 3
• 4
• 5
• ›